Evidence map›Paper›PMID 28377240›Full record

ArticleMolecular genetics and metabolism2017

Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls.

Gry B N Nordang, Øyvind L Busk, Kristian Tveten, Hans Ivar Hanevik, Anne Kristin M Fell, Jøran Hjelmesæth, Øystein L Holla, Jens K Hertel

Registry-linked trialOpen access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07302802 (Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07302802 recruitingstarted 2025, after this paper: background citation

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Ran2025Enrolled70Registered outcomes2Posted comparisons0ConditionsMonogenic ObesityArmsSemaglutide (administered by PDS290 pen-injector)
Open the trial in the graph
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. A comprehensive review of genetic causes of obesity.World journal of pediatrics : WJP · 2024
    Review
  9. Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar.The Journal of clinical endocrinology and metabolism · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2022
    Review
  15. Rare HeterozygousGenes · 2022
    Review
  16. Genetic obesity: an update with emerging therapeutic approaches.Annals of pediatric endocrinology & metabolism · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gry B N NordangMorbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway; Department of Occupational and Environmental Medicine, Telemark Hospital, Skien, Norway; Section of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital, Skien, Norway. Electronic address: grynor@sthf.no.
Øyvind L BuskSection of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital, Skien, Norway.
Kristian TvetenSection of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital, Skien, Norway.
Hans Ivar HanevikFertilitetsavdelingen Sør, Telemark Hospital, Porsgrunn, Norway.
Anne Kristin M FellDepartment of Occupational and Environmental Medicine, Telemark Hospital, Skien, Norway.
Jøran HjelmesæthMorbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Øystein L HollaSection of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital, Skien, Norway.
Jens K HertelMorbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway.
Telemark Hospital · NOSykehuset i Vestfold · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRare sequence variants in at least five genes are known to cause monogenic obesity. In this study we aimed to investigate the prevalence of, and characterize, rare coding and splice site variants in LEP, LEPR, MC4R, PCSK1 and POMC in patients with morbid obesity and normal weight controls.

methodTargeted next-generation sequencing of all exons in LEP, LEPR, MC4R, PCSK1 and POMC was performed in 485 patients with morbid obesity and 327 normal weight population-based controls from Norway.

resultsIn total 151 variants were detected. Twenty-eight (18.5%) of these were rare, coding or splice variants and five (3.3%) were novel. All individuals, except one control, were heterozygous for the 28 variants, and the distribution of the rare variants showed a significantly higher carrier frequency among cases than controls (9.9% vs. 4.9%, p=0.011). Four variants in MC4R were classified as pathogenic or likely pathogenic.

conclusionFour cases (0.8%) of monogenic obesity were detected, all due to MC4R variants previously linked to monogenic obesity. Significant differences in carrier frequencies among patients with morbid obesity and normal weight controls suggest an association between heterozygous rare coding variants in these five genes and morbid obesity. However, additional studies in larger cohorts and functional testing of the novel variants identified are required to confirm the findings.

Indexed as

Genetic VariationAdolescentAdultAge DistributionCase-Control StudiesChildFemaleGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansLeptinMaleMiddle AgedMutation RateNorwayObesity, MorbidLEPR protein, humanLeptinMC4R protein, humanPCSK1 protein, humanPro-OpiomelanocortinProprotein Convertase 1Receptor, Melanocortin, Type 4Receptors, LeptinBMIMorbid obesityMutationNext-generation sequencingRare sequence variant

Identifiers

PMID28377240
OpenAlexW2599315267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.